« Previous
Next »
Newborn and Infant Nursing Reviews
Volume 8, Issue 1
, Pages e1-e6
, March 2008
First-Trimester Nuchal Translucency Screening to Detect Down Syndrome
References
- Down syndrome. Retrieved June 21, 2006, from http://www.marchofdimes.com/professionals/681_1214.asp2006;
- . Screening for trisomy 21: the significance of a positive second trimester serum screen in women screen negative after a nuchal translucency scan. J Obstet Gynaecol. 2001;21:145–148
- . Choosing the best prenatal screening protocol. N Engl J Med. 2005;353:2068–2070
- Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18:636–637
- . A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol. 1985;151:1078–1079
- . Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?. J Perinat Med. 2005;33:191–198
- . First-trimester sonographic screening for Down syndrome. Obstet Gynecol. 2003;102:1066–1079
- Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig. 2006;13:209–216
- . Increased nuchal translucency pathophysiology. J Gynecol Obstet Biol Reprod. 2005;34:S89–S96
- . Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol. 2005;29:252–257
- Patient preference regarding first-trimester aneuploidy risk assessment. Am J Obstet Gynecol. 2005;193:1429–1436
- . Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol. 2004;24:735–739
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet. 1998;352:343–346
- Malone FD, Canick JA, Ball R, et al. First-trimester or second-trimester screening or both, for Down's syndrome. N Engl J Med 2005;353:2001-2011, 2068-2070.
- First-trimester screening for trisomies 21 and 18. N Engl J Med. 2003;349:1405–1413
- One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol. 2002;20:219–225
- Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?. Obstet Gynecol. 2002;100:648–654
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet and Gynecol. 2005;192:1761–1767
- First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn. 2004;24:774–780
- Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester. Fetal Diagn Ther. 2006;21:355–359
- Community-based screening for Down's syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG. 2005;112:1561–1564
- Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol. 2006;107:6–10
- Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol. 2005;26:154–157
- Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol. 2005;192:89–95
- Fetal cardiac defects and increased nuchal translucency thickness: a prospective study. Am J Obstet Gynecol. 2004;191:1486–1490
- . Nuchal translucency in pregnancies conceived after assisted reproduction technology. Curr Opin Obstet Gynecol. 2006;18:319–324
- . Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. J Obstet Gynaecol. 2005;25:579–582
- Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian, and Afro-Caribbean populations. Prenat Diagn. 2005;25:365–369
- . First trimester increased nuchal translucency associated with achondroplasia. Am J Perinatol. 2005;22:145–148
- Increased first-trimester fetal nuchal translucency thickness in association with chondroectodermal dysplasia (Ellis-Van Creveld syndrome). Ultrasound Obstet Gynecol. 2005;25:412–414
- Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol. 2005;193:322–326
- Are pregnant women making informed choices about prenatal screening?. Genet Med. 2005;7:332–338
- . Women's opinions on the offer and use of nuchal translucency screening for Down syndrome. Prenat Diagn. 2006;26:105–111
- . Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol. 2006;27:357–361
- Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study. Am J Obstet Gynecol. 2005;193:1260–1265
- . Psychological impact of antenatal diagnosis of increased nuchal transulency a women's pregnancy experience and mother-child relationship. J Gynecol Obstet Biol Reprod. 2005;34:S103
- Pregnant women's responses to information about an increased risk of carrying a baby with Down syndrome. Birth. 2006;33:64–73
- First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol. 2002;19:353–359
- Nuchal Translucency Quality Review Program. Available at: https://www.ntqr.org/SM/wfAboutUs.aspx2006;Retrieved June 18, 2006
- The effect of image size on screen-positive rates for nuchal translucency screening. BJOG. 2006;113:479–481
- Combined first trimester screening for trisomy 21: lack of agreement between risk calculation methods. J Perinat Med. 2006;34:162–165
- . Is 3-dimensional volume sonography an effective alternative method to the standard 2-dimensional technique of measuring the nuchal translucency?. J Clin Ultrasound. 2006;34:118–122
- A cost-effectiveness analysis of prenatal screening strategies for Down syndrome. Obstet Gynecol. 2005;106:562–568
PII: S1527-3369(07)00188-2
doi: 10.1053/j.nainr.2007.12.008
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Newborn and Infant Nursing Reviews
Volume 8, Issue 1
, Pages e1-e6
, March 2008
